Important note

This AI stock analysis for Atricure is not up to date. Creating and accessing our AI stock Analysis (powered by our data and Chat GPT) is only available for our premium users. Sign up to get access today!

Atricure - AI Stock Analysis

Analysis generated May 20, 2025

Atricure, Inc. is a leading provider of innovative surgical solutions that enable the treatment of complex cardiac conditions. The company specializes in the development, manufacture, and sale of surgical devices designed to create precision lesions for the treatment of cardiac arrhythmias. With a strong focus on innovation and patient outcomes, Atricure is dedicated to advancing the field of cardiac surgery and improving the quality of life for patients.

Headquartered in Mason, Ohio, Atricure has a global footprint with subsidiaries and sales networks spread across North America, Europe, and Asia. The company's mission is to outperform in delivering clinical value and provide robust solutions to its healthcare providers and patients.

Fundamental Analysis

Atricure reported a revenue of $124 million for the last quarter, which marks a 0.53% decrease compared to the previous quarter. However, this is offset by a significant 13.57% increase compared to the same quarter last year, indicating strong year-over-year growth.

Net income for the last quarter was reported at $6.7 million, reflecting a substantial improvement of 56.66% over the previous quarter, and a year-over-year increase of 49.15%. This impressive growth in net income is a strong indicator of the company's improving profitability.

Earnings before interest, taxes, depreciation, and amortization (EBITDA) for the last quarter stood at $6 million. This represents a 34.03% increase from the previous quarter and a year-over-year increase of 14.42%. The steady increase in EBITDA highlights the company’s effective cost management and operational efficiency.

Technical Analysis

Atricure's current stock price is $33.38, which is a 4.28% increase from a month ago, indicating a positive short-term trend. Over the past year, the stock price has shown a robust increase of 48.69%, underscoring a strong long-term bullish trend.

The Simple Moving Average (SMA10) is currently at 32.27, which is slightly higher than the previous SMA10 of 32.04. This indicates a potential upward trend in price movement. The Relative Strength Index (RSI) is at 50.7, suggesting that the stock is in a neutral condition, neither overbought nor oversold.

Alternative Data Analysis

Atricure currently has 69 open positions, which is a 7% decrease in the last couple of months. This reduction in hiring may indicate an effort to cut costs or improve margins, which is generally not a great sign for a company targeting aggressive growth.

Employee sentiment remains very high, with 89% of employees having a positive outlook. However, this sentiment has decreased by 5% in recent months, which might be a cause for concern.

The number of visitors to Atricure's webpage has doubled to 26,000 in the last couple of months, which is a bullish indicator as it suggests a potential increase in customer acquisition. Additionally, the company has seen an 8% increase in Instagram followers, reaching 850, indicating growing interest and engagement. Twitter followers remain steady at 2,600 with no significant change recently.

According to AltIndex’s AI score, which assesses a stock based on fundamental, technical, and alternative data, Atricure has a score of 58. This score suggests a hold recommendation.

Conclusion

Atricure presents a mixed but generally positive outlook. The company has demonstrated solid year-over-year revenue and net income growth, reflecting strong business fundamentals. The technical analysis indicates a bullish trend with a significant increase in stock price over the past year, supported by stable SMA and RSI figures.

However, the reduction in job postings and a slight dip in employee sentiment may indicate some underlying challenges. Conversely, the strong increase in web traffic and social media engagement suggests growing customer interest.

Based on the combined data, Atricure appears to be on a positive trajectory, but some caution is warranted. The current AI score of 58 suggests holding the stock. Investors should closely monitor future earnings reports and management's strategy to sustain and enhance growth.

Disclaimer: This AI stock analysis, generated by an experimental AI tool, is for informational purposes only and not financial advice. Information is based on publicly available data and may not always be accurate or current.